The next step is now to harness these newly discovered TDP‐43‐dependent cryptic splicing events and validate them in ALS and FTD patient tissue and biofluids (e.g., cerebrospinal fluid [CSF], blood urine) (Figure 2B). This evidence concerns the gene TARDBP and frontotemporal dementia.